U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 7

1.

Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer

(Submitter supplied) Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer, with approximately 50% of patients having residual disease after neoadjuvant chemotherapy (NACT) and worse prognosis with higher residual cancer burden (RCB). Patient-derived xenograft (PDX) models of breast cancer are an effective discovery platform and tool for preclinical pharmacologic testing and biomarker identification. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
207 Samples
Download data: CEL
Series
Accession:
GSE216333
ID:
200216333
2.

Epigenetic profiling of docetaxel resistance in Breast Cancer

(Submitter supplied) Illumina Infinium MethylationEPIC Beadchip was used to obtain DNA methylation profiles across 850000 CpGsites in nine different breast cancer PDX models. Docetaxel resistant and residual disease PDX models were also analyzed
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platforms:
GPL13534 GPL21145
70 Samples
Download data: CSV, IDAT, TXT
Series
Accession:
GSE110184
ID:
200110184
3.

Transcriptomic profiling of triple-negative breast cancer (TNBC) patient-derived xenografts (PDX) sensitive and resistant to docetaxel.

(Submitter supplied) SurePrint G3 Human Gene Expression Microarray v2 was used to obtain gene expression profiles of two different TNBC PDX models sensitive to docetaxel and in the docetaxel resistant TNBC PDX models derived from both initially sensitive.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16699
11 Samples
Download data: TXT
Series
Accession:
GSE110153
ID:
200110153
4.

p53 deficiency linked to BTG2 loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in PDX models of triple negative breast cancer

(Submitter supplied) We performed differential expression analyses from RNA-seq data derived from isogenic p53 wild-type and p53-knockdown triple negative breast tumors
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL15433
7 Samples
Download data: TXT
5.

Ex-vivo screening platform to identify tumor-specific therapies

(Submitter supplied) We report the generation of a preclinical IBC patient-derived xenograft (PDX)-derived ex vivo tumor tissue model and show that it closely replicates the tissue architecture of the original PDX tumor harvested from mice and show that its genetic signature highly correlates with that of the original tumor. We used microarrays to evaluate the robustness and reproducibility of the method used to generate the ex vivo tumor tissue model and confirm its ability to recapitulate the essential features of the original tumor.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL23126
8 Samples
Download data: CEL
Series
Accession:
GSE106685
ID:
200106685
6.

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

(Submitter supplied) Dysregulated choline metabolism is a well-known feature of breast cancer, but the underlying mechanisms are not fully understood. In this study, the metabolomic and transcriptomic characteristics of a large panel of human breast cancer xenograft models were mapped, with focus on choline metabolism. Methods: Tumor specimens from 34 patient-derived xenograft models were collected and divided in two. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14550
30 Samples
Download data: TXT
Series
Accession:
GSE44666
ID:
200044666
7.

Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts

(Submitter supplied) The VEGF targeted antiangiogenic drug bevacizumab has shown varying results in clinical trials of breast cancer. Identifying robust biomarkers for selecting patients that may benefit from bevacizumab treatment and for monitoring of response is important for the future use of this drug. Two established xenograft models representing basal-like and luminal-like breast cancer were used to study bevacizumab treatment response on the metabolic and gene expression levels. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
60 Samples
Download data: TXT
Series
Accession:
GSE37543
ID:
200037543
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_662b4ec1f4364867157eaeec|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center